Antitumor effects of internal iliac arterial infusion of platinum compounds in a rabbit cervical cancer model

Obstetrics and Gynecology

Volumn 89, Issue 2, 1997, Pages 286-290

  Itamochi, Hiroaki ^a   Kigawa, Junzo ^a   Minagawa, Yukihisa ^a   Cheng, Xiusi ^a   Okada, Makoto ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; NEDAPLATIN; PLATINUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG TUMOR LEVEL; FEMALE; HISTOLOGY; INFUSION; INTERNAL ILIAC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ANIMALS; FEMALE; ILIAC ARTERY; INFUSIONS, INTRA-ARTERIAL; PLATINUM COMPOUNDS; RABBITS; UTERINE CERVICAL NEOPLASMS;

EID: 0031081192     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(96)00480-2     Document Type: Article

References (15)

1. 1. Kigawa J, Kanamori Y, Ishihara H, Minagawa Y, Iwamoto K, Terakawa N. Response rate and cell-cycle changes due to intraarterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer. Am J Clin Oncol 1992;15: 474-9.
2. 2. Sardi J, Sananes C, Giaroli A, Maya G, Paola GD. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-93.
3. 3. Kigawa J, Minagawa Y, Ishihara H, Itamochi H, Kanamori Y, Terakawa N. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 1996;19:255-9.
4. 4. Sasaki Y, Shinkai T, Eguchi K, Tamura T, Ohe Y, Ohmori T, et al. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay. Cancer Chemother Pharmacol 1991;27:263-70.
5. 5. Okamoto M, Takao A, Fuzita H. Pharmacokinetics of cisplatin and new cisplatin analogues in experimental animals. Chemotherapy 1990;38:639-45.
6. 6. Chen HSG, Gross JF. Intra-arterial infusion of anticancer drugs: Theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980;64:31-40.
7. 7. Hecquet B, Vermin P, Fournier C, Poissonnier B. Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer. Cancer Res 1987;47: 6134-7.
8. 8. Kigawa J, Minagawa Y, Itamochi H, Kanamori Y, Ishihara H, Terakawa N. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits. Obstet Gynecol 1995;86:265-8.
9. 9. Rous P, Kidd JG, Smith WE. Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the VX2 carcinoma of the power to immunize hosts against the papilloma virus. J Exp Med 1952;96:159-74.
10. 10. LeRoy AF, Wehling ML, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, et al. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 1977;18:184-91.
11. 11. Furue H, Hara Y, Imai Y, Kimura T, Koyama Y, Kirihara M, et al. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 1993;28:101-30.
12. 12. Ramirez LH, Munck JN, Bognel C, Zhao Z, Ardouin P, Poupon MF, et al. Pharmacology and antitumor effects of intraportal pirarubicin on experimental liver metastases. Br J Cancer 1993;68: 277-81.
13. 13. Stephens FO. Pharmacokinetics of infra-arterial chemotherapy. Recent Results Cancer Res 1983;86:1-12.
14. 14. Akaza H, Togashi M, Nishio Y, Miki T, Kotake T, Matsumura Y, et al. Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. Cancer Chemother Pharmacol 1992;31:187-92.
15. 15. Canetta R, Rozencweig M, Carter SK. Carboplatin: The clinical spectrum to date. Cancer Treat Rev 1985;12:125-36.